Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
P Viale, CE Sandrock, P Ramirez, GM Rossolini… - Annals of intensive …, 2023 - Springer
Appropriate antibiotic treatment for critically ill patients with serious Gram-negative infections
in the intensive care unit is crucial to minimize morbidity and mortality. Several new …
in the intensive care unit is crucial to minimize morbidity and mortality. Several new …
In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates
M Takemura, R Nakamura, M Ota, R Nakai… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Achromobacter spp. and Burkholderia cepacia complex (Bcc) are rare but diverse
opportunistic pathogens associated with serious infections, which are often multidrug …
opportunistic pathogens associated with serious infections, which are often multidrug …
Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains
V Jean-Pierre, P Sorlin, A Pantel, R Chiron… - Annals of Clinical …, 2024 - Springer
Background Achromobacter spp. are opportunistic pathogens, mostly infecting
immunocompromised patients and patients with cystic fibrosis (CF) and considered as …
immunocompromised patients and patients with cystic fibrosis (CF) and considered as …
In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible …
JH Kimbrough, JM Maher, HS Sader… - Microbiology …, 2024 - journals.asm.org
This study reports the activity of cefiderocol against Enterobacterales, Pseudomonas
aeruginosa, and Acinetobacter spp. isolates collected from the United States and Europe …
aeruginosa, and Acinetobacter spp. isolates collected from the United States and Europe …
Recursive dynamics of GspE through machine learning enabled identification of inhibitors
Type II secretion System has been increasingly recognized as a key driver of virulence in
many pathogenic bacteria including Achromobacter xylosoxidans. ATPase GspE is the …
many pathogenic bacteria including Achromobacter xylosoxidans. ATPase GspE is the …
[HTML][HTML] Emergence of Achromobacter xylosoxidans Bacteremia in a Tertiary Care Center: A Case Report and Literature Review
KD Murthi, S Naik, SL Arumugam, J Manonmoney… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Achromobacter xylosoxidans (A. xylosoxidans) is an opportunistic pathogen that is
responsible for various nosocomial and community-acquired infections. It is often found in …
responsible for various nosocomial and community-acquired infections. It is often found in …
[HTML][HTML] A Rare Case of Autopsy Proven Achromobacter xylosoxidans Endocarditis Involving Tricuspid Valve: A Case Report
C Janga, M Kramer, I Naeem, L Checchio, Z Qamar - Cureus, 2023 - ncbi.nlm.nih.gov
Infective endocarditis refers to infection of one or more valves of the heart, with
Achromobacter xylosoxidans (A. xylosoxidans) being a rare cause. So far, 24 cases of A …
Achromobacter xylosoxidans (A. xylosoxidans) being a rare cause. So far, 24 cases of A …
[引用][C] Endocarditis infecciosa por Achromobacter xylosoxidans después de implante de válvula aórtica percutánea: a propósito de un caso
AB Pascual, JA Martín, CL Ruiz… - … Infecciosas y Microbiología …, 2024 - Elsevier